Research

Meet the Sanford Research scientist leading inspiring programs for students.

For centuries, the Lorraine Cross, also known as the crusader’s cross, has gained in significance around the world as a symbol. That very symbol has personal prominence in the mission of Sanford Health, representing hope and healing to those we serve. The importance of this symbol is underscored as an iconic part of the Sanford […]

One of the eight areas of focus at Sanford Research is pediatric and rare diseases. Generally, rare disease is defined as a disease that affects less than 200,000 people in the United States. About 7,000 of these diseases exist with treatments for less than five percent. Ben Forred, a project manager at Sanford Research, explains […]

Sanford Health has more than 350 ongoing clinical studies, 150 open clinical trials, and 24 open immunotherapy clinical trials that address 11 types of cancer. In 2016, Sanford Health was awarded the Association of Community Cancer Centers Institute for Clinical Immuno-Oncology Innovator Award for advancing Immuno-Oncology in the community setting. Recently, Sanford Health was honored […]

“Before, it was kind of this far-fetched idea that we see in movies, but now it is actually at our front door."

Sanford Health recently launched a clinical trial using a genetically engineered virus that aims to destroy therapy-resistant tumors. The Phase I immunotherapy trial is for those ages 18 and older with metastatic solid tumors that have not responded to standard treatments. The treatment injects a cancer-destroying virus into the tumor. The virus is engineered to […]

The Neonatal Research Network is the nation’s largest team of doctors, nurses and researchers performing clinical research for critically ill newborns admitted to neonatal intensive care units. There are only 15 sites selected to participate in the Neonatal Research Network. Sanford Health participates with the University of Iowa as the network’s Upper Midwest regional center. […]

The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., has reached the halfway point for enrollment and treatment. The project is studying the potential of CLBS03, Caladrius’ cell therapy consisting of each patient’s own regulatory T cells, or Tregs, to help the body fight type […]